Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications (Q38016491)

27 August 2017

Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications (English)

1 reference

chronic renal insufficiency

27 August 2017

1 reference

based on heuristic

inferred from title

microvasculature remodeling

1 reference

Marie Briet

1

1 reference

PubMed ID

22671427

27 August 2017

Kevin D Burns

series ordinal

2

1 reference

PubMed ID

22671427

27 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

123

1 reference

27 August 2017

399-416

1 reference

27 August 2017

7

1 reference

Chronic kidney disease and mortality risk: a systematic review

27 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The Framingham predictive instrument in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The emerging role of phosphate in vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial calcification and pathology in uremic patients undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Calciphylaxis in patients on hemodialysis: a prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The vascular lesions associated with skin necrosis in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Thematic series on the pathobiology of vascular calcification: an introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Bone morphogenetic proteins in vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Serum phosphate and mortality in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Association of serum phosphate with vascular and valvular calcification in moderate CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Serum phosphorus levels associate with coronary atherosclerosis in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial stiffness in predialysis patients with uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Preservation of function in experimental renal disease by dietary restriction of phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Role of calcium-phosphate deposition in vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The role of phosphorus in the development and progression of vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

FGF-23 as a predictor of renal outcome in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Current understanding of klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Klotho deficiency causes vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Chemical and hormonal determinants of vascular calcification in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Serum Levels of the Fetuin-Mineral Complex Correlate with Artery Calcification in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Molecular mechanisms of vascular calcification: lessons learned from the aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The regulation of valvular and vascular sclerosis by osteogenic morphogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Elastin calcification and its prevention with aluminum chloride pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

AT1 receptor blockade improves vasorelaxation in experimental renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Angiotensin II and the vascular phenotype in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The endothelin system and its antagonism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Increased ET-1 and reduced ET(B) receptor expression in uremic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Vascular endothelin in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Impaired endothelial function in isolated human uremic resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Flow-mediated vasodilation in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Dietary phosphorus acutely impairs endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Associations between circulating inflammatory markers and residual renal function in CRF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

The role of asymmetric and symmetric dimethylarginines in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Klotho protein protects against endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Regulation of oxidative stress by the anti-aging hormone klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Aortic and large artery compliance in end-stage renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Aortic PWV in chronic kidney disease: a CRIC ancillary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial remodeling associates with CKD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Arterial function after successful renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Evolution of arterial stiffness after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Aortic stiffness of kidney transplant recipients correlates with donor age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Cross-talk between macro- and microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Large and small artery cross-talk and recent morbidity-mortality trials in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Aortic stiffness and central wave reflections predict outcome in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Protective importance of the myogenic response in the renal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120074

21 January 2018

Identifiers

DOI

10.1042/CS20120074

1 reference

27 August 2017

1 reference

PubMed ID

22671427